CLAYTON RUSSELL (Chief Medical Officer) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/27/2026ACC: 0001193125-26-024832
Officer· Chief Medical Officer
Since Jan 2026
+179.46K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
179.46K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.64K
Price / share
—
Trade value
—
% of position
56.0%
1/26/2026
45.81K→71.44K
Total
Net shares
+25.64K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2026 | A · Award | +25.64K | — | — | 56.0% | 45.81K | 71.44K |
| Total | +25.64K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
153.82K shares
Shares
+153.82K
Strike price
3.60
Held after
153.82K
Exercisable
—
1/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock153.82K shares | 1/26/2026 | A · Award | +153.82K | 3.60 | — | 153.82K |